Axogen, Inc. (AXGN) stock
AXGNNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 11/30144% above fair value
$55.93+0.53 (+0.96%)
Close on Nov 13, 2026Market cap $3.34BP/E –Yield –
Axogen gross margin
Gross margin is gross profit as a percentage of revenue.
Axogen's gross margin for the twelve months ending Sep 30, 2026 was 74.2%. For fiscal 2025 it was 74.3%, against 75.8% the year before. The highest annual figure on record is 84.6% in fiscal 2018.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 74.3% | −1.5 |
| FY2024 | Dec 31, 2024 | 75.8% | −0.9 |
| FY2023 | Dec 31, 2023 | 76.6% | −1.9 |
| FY2022 | Dec 31, 2022 | 78.5% | −3.5 |
| FY2021 | Dec 31, 2021 | 82.0% | +1.2 |
| FY2020 | Dec 31, 2020 | 80.8% | −3.0 |
| FY2019 | Dec 31, 2019 | 83.7% | −0.9 |
| FY2018 | Dec 31, 2018 | 84.6% | +0.0 |
| FY2017 | Dec 31, 2017 | 84.6% | +0.3 |
| FY2016 | Dec 31, 2016 | 84.3% | +2.0 |
| FY2015 | Dec 31, 2015 | 82.3% | +2.7 |
| FY2014 | Dec 31, 2014 | 79.5% | +1.8 |
| FY2013 | Dec 31, 2013 | 77.7% | +3.2 |
| FY2012 | Dec 31, 2012 | 74.5% | +24.5 |
| FY2011 | Dec 31, 2011 | 50.0% | −4.1 |
| FY2010 | Dec 31, 2010 | 54.1% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 74.8% | −1.7 |
| Q2 FY2026 | Jun 30, 2026 | 72.7% | −1.5 |
| Q1 FY2026 | Mar 31, 2026 | 75.2% | +3.2 |
| Q4 FY2025 | Dec 31, 2025 | 74.1% | −1.9 |
| Q3 FY2025 | Sep 30, 2025 | 76.6% | +1.6 |
| Q2 FY2025 | Jun 30, 2025 | 74.2% | +0.4 |
| Q1 FY2025 | Mar 31, 2025 | 71.9% | −6.9 |
| Q4 FY2024 | Dec 31, 2024 | 76.1% | +1.5 |
| Q3 FY2024 | Sep 30, 2024 | 74.9% | −1.9 |
| Q2 FY2024 | Jun 30, 2024 | 73.8% | −3.9 |
| Q1 FY2024 | Mar 31, 2024 | 78.8% | +1.1 |
| Q4 FY2023 | Dec 31, 2023 | 74.6% | +7.1 |
| Q3 FY2023 | Sep 30, 2023 | 76.8% | −6.5 |
| Q2 FY2023 | Jun 30, 2023 | 77.7% | −4.0 |
| Q1 FY2023 | Mar 31, 2023 | 77.7% | −4.4 |
| Q4 FY2022 | Dec 31, 2022 | 67.5% | −15.3 |
| Q3 FY2022 | Sep 30, 2022 | 83.3% | +0.1 |
| Q2 FY2022 | Jun 30, 2022 | 81.8% | +2.9 |
| Q1 FY2022 | Mar 31, 2022 | 82.1% | −1.2 |
| Q4 FY2021 | Dec 31, 2021 | 82.8% | −0.4 |
| Q3 FY2021 | Sep 30, 2021 | 83.2% | +0.3 |
| Q2 FY2021 | Jun 30, 2021 | 78.9% | +4.2 |
| Q1 FY2021 | Mar 31, 2021 | 83.3% | +3.2 |
| Q4 FY2020 | Dec 31, 2020 | 83.2% | +0.5 |
| Q3 FY2020 | Sep 30, 2020 | 83.0% | −1.3 |
| Q2 FY2020 | Jun 30, 2020 | 74.7% | −9.4 |
| Q1 FY2020 | Mar 31, 2020 | 80.1% | −3.9 |
| Q4 FY2019 | Dec 31, 2019 | 82.7% | −1.8 |
| Q3 FY2019 | Sep 30, 2019 | 84.2% | −0.5 |
| Q2 FY2019 | Jun 30, 2019 | 84.1% | −0.8 |
| Q1 FY2019 | Mar 31, 2019 | 84.0% | −0.2 |
| Q4 FY2018 | Dec 31, 2018 | 84.5% | −0.1 |
| Q3 FY2018 | Sep 30, 2018 | 84.7% | +0.3 |
| Q2 FY2018 | Jun 30, 2018 | 84.9% | −0.1 |
| Q1 FY2018 | Mar 31, 2018 | 84.3% | −0.1 |
| Q4 FY2017 | Dec 31, 2017 | 84.6% | +0.6 |
| Q3 FY2017 | Sep 30, 2017 | 84.4% | – |
| Q2 FY2017 | Jun 30, 2017 | 85.0% | – |
| Q1 FY2017 | Mar 31, 2017 | 84.3% | – |
| Q4 FY2016 | Dec 31, 2016 | 84.0% | – |
See a number that looks wrong?